Company intelligence / Profile preview

Evaluate

London, England, United Kingdom

Ownership: Private
Employees: ~350
Development stage: Other

Overview

Evaluate delivers comprehensive commercial intelligence solutions to the global pharmaceutical industry by integrating real-world data, technology-driven analytics, and expert consulting. Their services support strategic decision-making across portfolio management, opportunity assessment, competitive analysis, asset valuation, and deal benchmarking. The company does not conduct clinical trials or have a drug pipeline but is widely used by biopharma stakeholders to inform R&D investment decisions.

Industry: Biomedical IT and Biomedical Data Platforms

Partnerships

Notable partnerships with major pharma/biotech clients who use their analytics tools

Beyond the preview

Go deeper on Evaluate.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Evaluate.